Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
    February 2021
  1. ANGERSTEIN AO, Stoneham CA, Ramirez PW, Guatelli JC, et al
    Corrigendum to "Sensitivity to monoclonal antibody 447-52D and an open env trimer conformation correlate poorly with inhibition of HIV-1 infectivity by SERINC5" [Virology 2020 548, 73-81].
    Virology. 2021 Feb 10. pii: S0042-6822(21)00035.
    >> Share

  2. MONDAL S, Karmakar A, Mallick T, Begum NA, et al
    Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion.
    Virology. 2021;556:133-139.
    >> Share

  3. JAGUVA VASUDEVAN AA, Balakrishnan K, Franken A, Krikoni A, et al
    Murine leukemia virus resists producer cell APOBEC3A by its Glycosylated Gag but not target cell APOBEC3A.
    Virology. 2021;557:1-14.
    >> Share

    December 2020
  4. OJWACH DBA, Madlala P, Gordon M, Ndung'u T, et al
    Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.
    Virology. 2020;554:1-8.
    >> Share

  5. ZHANG Z, Perkovic M, Gu Q, Balakrishnan K, et al
    HIV-2 Vif and foamy virus Bet antagonize APOBEC3B by different mechanisms.
    Virology. 2020;554:17-27.
    >> Share

    October 2020
  6. MCQUAID IK, Dorfman JR, Mall AS
    The comparative inhibitory potency of salivary mucins against human immunodeficiency virus type 1.
    Virology. 2020;553:1-8.
    >> Share

    September 2020
  7. SHA SS, Dai Z, Wei QZ, Tao HX, et al
    Characteristics of HIV-1 env genes from Chinese chronically infected donors with highly broad cross-neutralizing activity.
    Virology. 2020;551:16-25.
    >> Share

  8. WIECZOREK L, Peachman K, Steers N, Schoen J, et al
    Selection and immune recognition of HIV-1 MPER mimotopes.
    Virology. 2020;550:99-108.
    >> Share

  9. ANGERSTEIN AO, Stoneham CA, Ramirez PW, Guatelli JC, et al
    Sensitivity to monoclonal antibody 447-52D and an open env trimer conformation correlate poorly with inhibition of HIV-1 infectivity by SERINC5.
    Virology. 2020;548:73-81.
    >> Share

  10. WIECZOREK L, Peachman K, Adams DJ, Barrows B, et al
    Evaluation of HIV-1 neutralizing and binding antibodies in maternal-infant transmission in Thailand.
    Virology. 2020;548:152-159.
    >> Share

  11. WANG Y, Zhang Y, Tang T, Zhao W, et al
    Natural killer cell counts in primary HIV infection predicts disease progression and immune restoration after treatment.
    Virology. 2020;550:89-98.
    >> Share

    March 2020
  12. NDLOVU B, Gounder K, Muema D, Raju N, et al
    Envelope characteristics in individuals who developed neutralizing antibodies targeting different epitopes in HIV-1 subtype C infection.
    Virology. 2020;546:1-12.
    >> Share

  13. MOAR P, Sushmita K, Kateriya S, Tandon R, et al
    Transcriptional profiling indicates cAMP-driven reversal of HIV latency in monocytes occurs via transcription factor SP-1.
    Virology. 2020;542:40-53.
    >> Share

    February 2020
  14. ALEXANDRE K, Malatji K, Mulaudzi T
    Comparison of the antiviral activity of the microbicide candidate griffithsin and its tandemers derivatives against different modes of HIV-1 transmission.
    Virology. 2020;544:12-20.
    >> Share

    November 2019
  15. ISHAQ M, Marshall H, Natarajan V
    GADD34 attenuates HIV-1 replication by viral 5'-UTR TAR RNA-mediated translational inhibition.
    Virology. 2019;540:119-131.
    >> Share

  16. LEDA AR, Hunter J, Castro de Oliveira U, Junqueira de Azevedo I, et al
    HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naive recently infected individuals.
    Virology. 2019;541:13-24.
    >> Share

    October 2019
  17. FORBERG K, Rodgers MA, Dawson GJ, Sauleda S, et al
    Human pegivirus 2 exhibits minimal geographic and temporal genetic diversity.
    Virology. 2019;539:69-79.
    >> Share

  18. SARIBAS AS, Datta PK, Safak M
    A comprehensive proteomics analysis of JC virus Agnoprotein-interacting proteins: Agnoprotein primarily targets the host proteins with coiled-coil motifs.
    Virology. 2019;540:104-118.
    >> Share

  19. LIU H, Hu PW, Budhiraja S, Misra A, et al
    PACS1 is an HIV-1 cofactor that functions in Rev-mediated nuclear export of viral RNA.
    Virology. 2019;540:88-96.
    >> Share

  20. CARO-VEGAS C, Sellers S, Host KM, Seltzer J, et al
    Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels.
    Virology. 2019;539:18-25.
    >> Share

    September 2019
  21. STAUBUS AO, Alfadhli A, Barklis RL, Barklis E, et al
    Replication of HIV-1 envelope protein cytoplasmic domain variants in permissive and restrictive cells.
    Virology. 2019;538:1-10.
    >> Share

    August 2019
  22. COGGINS SA, Holler JM, Kimata JT, Kim DH, et al
    Efficient pre-catalytic conformational change of reverse transcriptases from SAMHD1 non-counteracting primate lentiviruses during dNTP incorporation.
    Virology. 2019;537:36-44.
    >> Share

    July 2019
  23. CHEN J, Del Valle L, Lin HY, Plaisance-Bonstaff K, et al
    Expression of PD-1 and PD-Ls in Kaposi's sarcoma and regulation by oncogenic herpesvirus lytic reactivation.
    Virology. 2019;536:16-19.
    >> Share

  24. FABRIZIO C, Bavaro DF, Scudeller L, Lepore L, et al
    Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates.
    Virology. 2019;535:266-271.
    >> Share

  25. GONCALES JP, Silva Junior JVJ, Lopes TRR, Tozetto-Mendoza TR, et al
    Association of polymorphisms in NFkappaB1 promoter and NFkappaBIA gene with the development of antibodies against HHV-8 in HIV-infected individuals.
    Virology. 2019;535:255-260.
    >> Share

    June 2019
  26. WOODSON E, Basu D, Olszewski H, Gilmour J, et al
    Reduced frequency of HIV superinfection in a high-risk cohort in Zambia.
    Virology. 2019;535:11-19.
    >> Share

  27. MEADOR LR, Kessans SA, Kilbourne J, Kibler KV, et al
    Corrigendum to "A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles" [Virology 507 (2017) 242-256].
    Virology. 2019 Jun 6. pii: S0042-6822(19)30139.
    >> Share

    April 2019
  28. SAITO A, Ode H, Nohata K, Ohmori H, et al
    HIV-1 is more dependent on the K182 capsid residue than HIV-2 for interactions with CPSF6.
    Virology. 2019;532:118-126.
    >> Share

  29. HIKICHI Y, Takeda E, Fujino M, Nakayama E, et al
    HIV-1 matrix mutations that alter gag membrane binding modulate mature core formation and post-entry events.
    Virology. 2019;532:97-107.
    >> Share

    March 2019
  30. BUFFONE C, Kutzner J, Opp S, Martinez-Lopez A, et al
    The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB.
    Virology. 2019;531:260-268.
    >> Share

    February 2019
  31. NAIDOO L, Mzobe Z, Jin SW, Rajkoomar E, et al
    Nef-mediated inhibition of NFAT following TCR stimulation differs between HIV-1 subtypes.
    Virology. 2019;531:192-202.
    >> Share

  32. JIN SW, Markle TJ, Anmole G, Rahimi A, et al
    Modulation of TCR-dependent NFAT signaling is impaired in HIV-1 Nef isolates from elite controllers.
    Virology. 2019;530:39-50.
    >> Share

    January 2019
  33. LI D, Rawle DJ, Wu Z, Jin H, et al
    eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency.
    Virology. 2019;530:65-74.
    >> Share

  34. KHAN AS, Bodem J, Buseyne F, Gessain A, et al
    Corrigendum to "Spumaretroviruses: Updated taxonomy and nomenclature" [Virology 516 (2018) 158-164].
    Virology. 2019 Jan 20. pii: S0042-6822(18)30390.
    >> Share

  35. LIU L, Li L, Nanfack A, Mayr LM, et al
    Anti-V2 antibody deficiency in individuals infected with HIV-1 in Cameroon.
    Virology. 2019;529:57-64.
    >> Share

    November 2018
  36. MOHAMMADZADEH N, Follack TB, Love RP, Stewart K, et al
    Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies.
    Virology. 2018;527:21-31.
    >> Share

  37. LI H, Chen BK
    Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones.
    Virology. 2018;526:189-202.
    >> Share

    September 2018
  38. CONNOLLY S, Wall KM, Tang J, Yu T, et al
    Fc-gamma receptor IIA and IIIA variants in two African cohorts: Lack of consistent impact on heterosexual HIV acquisition, viral control, and disease progression.
    Virology. 2018;525:132-142.
    >> Share

  39. LIU Y, Guan X, Li C, Ni F, et al
    HSV-2 glycoprotein J promotes viral protein expression and virus spread.
    Virology. 2018;525:83-95.
    >> Share

    August 2018
  40. ZICARI S, Arakelyan A, Palomino RAN, Fitzgerald W, et al
    Human cytomegalovirus-infected cells release extracellular vesicles that carry viral surface proteins.
    Virology. 2018;524:97-105.
    >> Share

  41. GIULIANI E, Vassena L, Galardi S, Michienzi A, et al
    Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu.
    Virology. 2018;523:121-128.
    >> Share

  42. MEIER K, Jaguva Vasudevan AA, Zhang Z, Bahr A, et al
    Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV).
    Virology. 2018;523:52-63.
    >> Share

  43. NUNES JM, Furtado MN, de Morais Nunes ER, Sucupira MCA, et al
    Modulation of epigenetic factors during the early stages of HIV-1 infection in CD4(+) T cells in vitro.
    Virology. 2018;523:41-51.
    >> Share

    July 2018
  44. SELYUTINA A, Bulnes-Ramos A, Diaz-Griffero F
    Binding of host factors to stabilized HIV-1 capsid tubes.
    Virology. 2018;523:1-5.
    >> Share

  45. LIU H, Hu PW, Couturier J, Lewis DE, et al
    HIV-1 replication in CD4(+) T cells exploits the down-regulation of antiviral NEAT1 long non-coding RNAs following T cell activation.
    Virology. 2018;522:193-198.
    >> Share

  46. JAGUVA VASUDEVAN AA, Bahr A, Grothmann R, Singer A, et al
    MXB inhibits murine cytomegalovirus.
    Virology. 2018;522:158-167.
    >> Share

    June 2018
  47. GUO J, Liu X, Wu C, Hu J, et al
    The transmembrane nucleoporin Pom121 ensures efficient HIV-1 pre-integration complex nuclear import.
    Virology. 2018;521:169-174.
    >> Share

  48. BOWDER D, Hollingsead H, Durst K, Hu D, et al
    Contribution of the gp120 V3 loop to envelope glycoprotein trimer stability in primate immunodeficiency viruses.
    Virology. 2018;521:158-168.
    >> Share

  49. HONG F, Jacobs JL, Aga E, Cillo AR, et al
    Associations between HIV-1 DNA copy number, proviral transcriptional activity, and plasma viremia in individuals off or on suppressive antiretroviral therapy.
    Virology. 2018;521:51-57.
    >> Share

  50. TIMILSINA U, Ghimire D, Adhikari LP, Bhattarai A, et al
    Maturation inhibitors facilitate virus assembly and release of HIV-1 capsid P224 mutant.
    Virology. 2018;521:44-50.
    >> Share

    May 2018
  51. MEFFERD AL, Bogerd HP, Irwan ID, Cullen BR, et al
    Insights into the mechanisms underlying the inactivation of HIV-1 proviruses by CRISPR/Cas.
    Virology. 2018;520:116-126.
    >> Share

  52. MARSDEN MD, Wu X, Navab SM, Loy BA, et al
    Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents.
    Virology. 2018;520:83-93.
    >> Share

  53. BOWDER D, Thompson J, Durst K, Hollingsead H, et al
    Characterization of twin-cysteine motif in the V2-loop region of gp120 in primate lentiviruses.
    Virology. 2018;519:180-189.
    >> Share

    April 2018
  54. BOLIAR S, Patil S, Shukla BN, Ghobbeh A, et al
    Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category.
    Virology. 2018;519:99-105.
    >> Share

    March 2018
  55. ZHANG Y, Lu J, Liu X
    MARCH2 is upregulated in HIV-1 infection and inhibits HIV-1 production through envelope protein translocation or degradation.
    Virology. 2018;518:293-300.
    >> Share

  56. BARKLIS E, Staubus AO, Mack A, Harper L, et al
    Lipid biosensor interactions with wild type and matrix deletion HIV-1 Gag proteins.
    Virology. 2018;518:264-271.
    >> Share

  57. MELTZER B, Dabbagh D, Guo J, Kashanchi F, et al
    Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages.
    Virology. 2018;518:241-252.
    >> Share

    February 2018
  58. DEBOER J, Wojtkiewicz MS, Haverland N, Li Y, et al
    Proteomic profiling of HIV-infected T-cells by SWATH mass spectrometry.
    Virology. 2018;516:246-257.
    >> Share

  59. KHAN AS, Bodem J, Buseyne F, Gessain A, et al
    Spumaretroviruses: Updated taxonomy and nomenclature.
    Virology. 2018;516:158-164.
    >> Share

    January 2018
  60. SERTZNIG H, Hillebrand F, Erkelenz S, Schaal H, et al
    Behind the scenes of HIV-1 replication: Alternative splicing as the dependency factor on the quiet.
    Virology. 2018;516:176-188.
    >> Share

  61. ZHANG M, Robinson TO, Duverger A, Kutsch O, et al
    Regulatory CD4 T cells inhibit HIV-1 expression of other CD4 T cell subsets via interactions with cell surface regulatory proteins.
    Virology. 2018;516:21-29.
    >> Share

  62. CHUA BA, Ngo JA, Situ K, Ramirez CM, et al
    Protein S and Gas6 induce efferocytosis of HIV-1-infected cells.
    Virology. 2018;515:176-190.
    >> Share

    December 2017
  63. YASEN A, Herrera R, Rosbe K, Lien K, et al
    HIV internalization into oral and genital epithelial cells by endocytosis and macropinocytosis leads to viral sequestration in the vesicles.
    Virology. 2017;515:92-107.
    >> Share

  64. SCHULTE B, Selyutina A, Opp S, Herschhorn A, et al
    Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5.
    Virology. 2017;515:52-65.
    >> Share

  65. PREVOST J, Richard J, Ding S, Pacheco B, et al
    Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals.
    Virology. 2017;515:38-45.
    >> Share

    November 2017
  66. HOGAN MJ, Conde-Motter A, Jordan APO, Yang L, et al
    Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization.
    Virology. 2017;514:106-117.
    >> Share

  67. LIU Y, Chen J, Nikolaitchik OA, Desimmie BA, et al
    The roles of five conserved lentiviral RNA structures in HIV-1 replication.
    Virology. 2017;514:1-8.
    >> Share

    October 2017
  68. DIAZ F, Gregory S, Nakashima H, Viapiano MS, et al
    Intramuscular delivery of replication-defective herpes simplex virus gives antigen expression in muscle syncytia and improved protection against pathogenic HSV-2 strains.
    Virology. 2017;513:129-135.
    >> Share

  69. SCHWARTZ EJ, Vaidya NK, Dorman KS, Carpenter S, et al
    Dynamics of lentiviral infection in vivo in the absence of adaptive immune responses.
    Virology. 2017;513:108-113.
    >> Share

  70. MA TC, Le Guo, Zhou RH, Wang X, et al
    Soybean-derived Bowman-Birk inhibitor (BBI) blocks HIV entry into macrophages.
    Virology. 2017;513:91-97.
    >> Share

  71. DUFRASNE FE, Lucchetti M, Martin A, Andre E, et al
    Modulation of the NF-kappaB signaling pathway by the HIV-2 envelope glycoprotein and its incomplete BST-2 antagonism.
    Virology. 2017;513:11-16.
    >> Share

  72. YUE Y, Coskun AK, Jawanda N, Auer J, et al
    Differential interaction between human and murine Crm1 and lentiviral Rev proteins.
    Virology. 2017;513:1-10.
    >> Share

  73. JOSHI A, Cox EK, Sedano MJ, Punke EB, et al
    HIV-1 subtype CRF01_AE and B differ in utilization of low levels of CCR5, Maraviroc susceptibility and potential N-glycosylation sites.
    Virology. 2017;512:222-233.
    >> Share

    September 2017
  74. NAHABEDIAN J, Sharma A, Kaczmarek ME, Wilkerson GK, et al
    Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry.
    Virology. 2017;512:180-186.
    >> Share

  75. JIA M, Shaw T, Zhang X, Liu D, et al
    Decoding noises in HIV computational genotyping.
    Virology. 2017;511:249-255.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016